CEO of Novo Nordisk to step down in wake of share price drop
Danish pharmaceutical company Novo Nordisk A/S said Friday its CEO was stepping down by “mutual agreement” with the company's board of directors, citing “recent market challenges” and a steep decline in the company's share price.... Read More
